top of page

Search

Available Now - Resoundant Spring Newsletter

Resoundant
May 31, 2023
1 min read

Get caught up on all-things-MRE with our spring newsletter.

Read more here: https://www.resoundant.com/so/f7OVT2W4C?languageTag=en

Recent Posts

Resoundant Appoints Kay Pepin, PhD, as Chief Operating Officer

Resoundant Appoints Kay Pepin, PhD, as Chief Operating Officer

Resoundant Applauds FDA Approval of Resmetirom: A Milestone for MASLD and MASH Patients

Rochester, MN – Resoundant, a Mayo Clinic company and the developer of Magnetic Resonance Elastography (MRE), is thrilled to announce the...

Study: Utility and impact of magnetic resonance elastography in the clinical course and management of chronic liver disease

Colin Feuille, Swathi Kari, Roshan Patel, Rohan Oberoi, Jonathan Liu, Michael Ohliger, Mandana Khalili & Michele Tana Scientific Reports...

Comments

Recent Posts

Resoundant Appoints Kay Pepin, PhD, as Chief Operating Officer

Resoundant Applauds FDA Approval of Resmetirom: A Milestone for MASLD and MASH Patients

Study: Utility and impact of magnetic resonance elastography in the clinical course and management of chronic liver disease

Renaming NAFLD: The Importance and Implications of the Transition to MASLD

Available Now - Resoundant Spring Newsletter

bottom of page